Cryoport Talks Compliance, Biopharma Expansion, and Brexit - Outsourcing-Pharma

November 13, 2018

Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport in a recent Outsourcing-Pharma feature. Read Full Article >


Building an unbreakable Chain of Compliance™ - BioPharma Dealmakers

November 05, 2018

Regenerative medicine advanced therapies in the form of cell and gene therapies are breaking new ground, providing patients the potential of treatment, reversal or even cure of serious and life-threatening conditions, including genetic disorders and cancer. The logistics and supply chains for these therapies, particularly those that involve the manipulation of autologous cells, can be complex, and there are many points in the chain in which the cells are vulnerable to accidental diversion or temperature deviation. In a recent feature in BioPharma Dealmakers, the importance of Chain of Compliance™ is revealed and explained:  Read Full Article >


Cryoport Tackles Market Needs with New NJ Facility - Contract Pharma

November 02, 2018

Cryoport recently unveiled its newest Global Logistics Center, based in Livingston, New Jersey with a ribbon-cutting ceremony attended by several of Cryoport’s clients, local dignitaries and business partners. Contract Pharma spoke with Cryoport’s CEO, Jerry Shelton, on the reasons behind the new Global Logistics Center's launch. Read Full Article > 


Expert Opinion: The Latest Insight on the Life Sciences Supply Chain - ASIA Outlook

October 29, 2018

Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, offers his take on why the life sciences cold chain space continues to grow apace in Asia Pacific and how supply chains can keep up with ever-complex demands.  Read Article >


Why the Cold Chain is Striking Hot - ASIA Outlook

October 29, 2018

Find out why the life science temperature-controlled space continues to grow apace in Asia Pacific and how supply chains can keep up with every-complex demands in a recent ASIA Outlook article by Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport:  Read Article >


Be The Match BioTherapies, Cryoport Enter Agreement - Contract Pharma

October 04, 2018

Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry. The collaboration will support both organizations’ efforts to standardize critical elements of the cell therapy supply chain, as well as processes in apheresis and transplant center networks. Read Full Article > 


Quality Systems for Regenerative Medicine Delivery; Basic Quality Requirements for Distribution - World Pharma Today

August 20, 2018

The emergence of regenerative medicine as a viable therapy class has created an urgency to review and improve upon the current quality systems distribution standards that are employed in support of these therapies. In a recent World Pharma Today featured article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses the emerging Chain of ComplianceTM requirements for regenerative medicine distribution. Read more >


Cryoport, World Courier Ink Logistics Deal for Gene Therapies - Logistics for the Life Sciences

July 17, 2018

Cryoport, Inc. announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled products into its global network. This integrated platform offers complete Chain of Compliance™ solutions for biopharmaceutical companies, ensuring full traceability of equipment, processes, and handling of cell and gene therapies while in transit. Read Full Article > 


The Chain of Compliance™ - Contract Pharma

June 14, 2018

Chain of Compliance™ is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses why the Chain of Compliance™ is critical to winning in the RMAT market.  Read more >


Exclusive interview with Cryoport CEO - Gasworld

April 10, 2018

Gasworld spoke to Jerry Shelton, Cryoport’s CEO, to find out how the latest regenerative medicines wouldn’t be possible without an often overlooked, yet extremely important component: logistics.s. Read Full Interview >